Rapid high resolution genotyping of Francisella tularensis by whole genome sequence comparison of annotated genes ("MLST+")

PLoS One. 2015 Apr 9;10(4):e0123298. doi: 10.1371/journal.pone.0123298. eCollection 2015.

Abstract

The zoonotic disease tularemia is caused by the bacterium Francisella tularensis. This pathogen is considered as a category A select agent with potential to be misused in bioterrorism. Molecular typing based on DNA-sequence like canSNP-typing or MLVA has become the accepted standard for this organism. Due to the organism's highly clonal nature, the current typing methods have reached their limit of discrimination for classifying closely related subpopulations within the subspecies F. tularensis ssp. holarctica. We introduce a new gene-by-gene approach, MLST+, based on whole genome data of 15 sequenced F. tularensis ssp. holarctica strains and apply this approach to investigate an epidemic of lethal tularemia among non-human primates in two animal facilities in Germany. Due to the high resolution of MLST+ we are able to demonstrate that three independent clones of this highly infectious pathogen were responsible for these spatially and temporally restricted outbreaks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Zoo
  • Arvicolinae*
  • Base Sequence
  • Cluster Analysis
  • Computational Biology
  • Databases, Genetic
  • Disease Outbreaks / veterinary*
  • Francisella tularensis / genetics*
  • Genome, Bacterial / genetics*
  • Genotyping Techniques / methods*
  • Haplorhini
  • Humans
  • Molecular Sequence Annotation
  • Molecular Sequence Data
  • Monkey Diseases / microbiology*
  • Phylogeny
  • Rodent Diseases / microbiology*
  • Sequence Analysis, DNA
  • Tularemia / epidemiology
  • Tularemia / veterinary*

Grants and funding

This work was supported in part by the German Ministry of Health [BMG] and the Robert-Koch-Institute under contract FKZ 1369-372 and by the European Community's Seventh Framework Program [grant number FP7/2007-2013 to DH] under Grant Agreement N° 278864 in the framework of the EU PathoNGenTrace project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.